Kindred Healthcare, Inc. (NYSE:KND) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

A number of other research analysts have also commented on KND. BidaskClub lowered shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Deutsche Bank AG lowered their price objective on shares of Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, August 7th. Royal Bank Of Canada lowered their price objective on shares of Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating on the stock in a research note on Thursday, September 21st. Bank of America Corporation lowered their price objective on shares of Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a research note on Thursday, September 21st. Finally, Mizuho reiterated a “neutral” rating and set a $7.50 price objective (down previously from $8.00) on shares of Kindred Healthcare in a research note on Tuesday, October 10th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $8.86.

Kindred Healthcare (NYSE:KND) traded up $0.40 during midday trading on Tuesday, hitting $8.20. 841,700 shares of the company were exchanged, compared to its average volume of 1,198,287. Kindred Healthcare has a fifty-two week low of $5.50 and a fifty-two week high of $11.90. The company has a quick ratio of 1.53, a current ratio of 1.55 and a debt-to-equity ratio of 6.22. The firm has a market capitalization of $678.07, a price-to-earnings ratio of 39.00 and a beta of 1.12.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.08. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same quarter last year, the business earned $0.05 earnings per share. The business’s revenue for the quarter was down 5.5% on a year-over-year basis. analysts forecast that Kindred Healthcare will post 0.27 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Kindred Healthcare, Inc. (KND) Upgraded to Hold at Zacks Investment Research” was reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/11/23/kindred-healthcare-inc-knd-upgraded-to-hold-at-zacks-investment-research.html.

Institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. grew its position in Kindred Healthcare by 149.4% in the second quarter. JPMorgan Chase & Co. now owns 2,104,618 shares of the health services provider’s stock worth $24,518,000 after buying an additional 1,260,753 shares during the last quarter. Bank of New York Mellon Corp grew its position in Kindred Healthcare by 2.4% in the second quarter. Bank of New York Mellon Corp now owns 1,488,869 shares of the health services provider’s stock worth $17,345,000 after buying an additional 34,553 shares during the last quarter. Smith Graham & Co. Investment Advisors LP grew its position in Kindred Healthcare by 39.6% in the third quarter. Smith Graham & Co. Investment Advisors LP now owns 1,238,980 shares of the health services provider’s stock worth $8,425,000 after buying an additional 351,280 shares during the last quarter. BlackRock Inc. grew its position in Kindred Healthcare by 0.3% in the second quarter. BlackRock Inc. now owns 10,808,864 shares of the health services provider’s stock worth $125,923,000 after buying an additional 29,673 shares during the last quarter. Finally, Teachers Advisors LLC grew its position in Kindred Healthcare by 8.1% in the second quarter. Teachers Advisors LLC now owns 162,452 shares of the health services provider’s stock worth $1,893,000 after buying an additional 12,132 shares during the last quarter. Hedge funds and other institutional investors own 88.62% of the company’s stock.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.